Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 858

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 858
---
 statement/prospectus).***                                    | ​ |
| ​ |        2.7 | ​ | ​ | Sixth Amendment to Business Combination Agreement, dated as of October 23, 2024, by and among Iris Acquisition Corp, Iris Parent Holding Corp. and Liminatus Pharma, LLC (included as Annex A to the proxy statement/prospectus).***                                   | ​ |
| ​ |        2.8 | ​ | ​ | Seventh Amendment to Business Combination Agreement, dated as of December 26, 2024, by and among Iris Acquisition Corp, Iris Parent Holding Corp. and Liminatus Pharma, LLC (included as Annex A to the proxy statement/prospectus).*                                  | ​ |
| ​ |        3.1 | ​ | ​ | Certificate of Incorporation of Iris Parent Holding Corp. (to be renamed Liminatus Pharma, Inc.)***                                                                                                                                                                    | ​ |
| ​ |        3.2 | ​ | ​ | Form of Amended and Restated Certificate of Incorporation of Iris Parent Holding Corp. (to be renamed Liminatus Pharma, Inc.) (included as Annex C to the proxy statement/prospectus).***                                                                              | ​ |
| ​ |        3.3 | ​ | ​ | Bylaws of Iris Parent Holding Corp. (to be renamed Liminatus Pharma, Inc.) ***                                                                                                                                                                                         | ​ |
| ​ |        3.4 | ​ | ​ | Form of Amended and Restated Bylaws of Iris Parent Holding Corp. (to be renamed Liminatus Pharma, Inc.) (included as Annex I to the proxy statement/prospectus)***                                                                                                     | ​ |

II-1

TABLE OF CONTENTS

| ​ 
 ​ 
 ​ 
 ​ | ExhibitNo. 
        4.1 
        4.2 
        4.3 | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Description                                                                                                                                                                                                                                                                   
 Specimen Common Stock Certificate.***                                                                                                                                                                                                                                         
 Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 of the Form S-1/A of Iris Acquisition Corp filed March 3, 2021).***                                                                                                                                    
 Warrant Agreement between Continental Stock Transfer & Trust Company and Iris Acquisition Corp (incorporated by reference to Exhibit 4.1 of the Form 8-K of Iris Acquisition Corp filed March 10, 2021).***                                                                   | ​ 
 ​ 
 ​ 
 ​ |
|:--|